Skip to content

Drug interactions

Nateglinide + Ticlopidine

Severity: Moderate

Nateglinide and Ticlopidine: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Ticlopidine may inhibit CYP2C9 and raise nateglinide exposure, potentially causing hypoglycemia. The effect is expected to be modest.

What this interaction means in plain words

Nateglinide and Ticlopidine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Nateglinide belongs to Endocrine; Ticlopidine belongs to Cardiovascular.

Evidence level: Low

Why it happens

Inhibition of CYP2C9-mediated nateglinide metabolism by ticlopidine.

What to do

Monitor blood glucose when ticlopidine is started or stopped and counsel on hypoglycemia symptoms. Reduce nateglinide dose if hypoglycemia occurs.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Nateglinide and Ticlopidine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Nateglinide with Ticlopidine?

MediHelp rates the interaction as moderate. Nateglinide and Ticlopidine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Ticlopidine may inhibit CYP2C9 and raise nateglinide exposure, potentially causing hypoglycemia. The effect is expected to be modest.

How serious is the interaction between Nateglinide and Ticlopidine?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood glucose when ticlopidine is started or stopped and counsel on hypoglycemia symptoms. Reduce nateglinide dose if hypoglycemia occurs.

What other medicines interact with Ticlopidine?

MediHelp also lists interactions of Ticlopidine with, for example, Mavacamten, Abrocitinib, Acetylsalicylic acid. The full list is on the Ticlopidine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in